A prescription for equity: ensuring young Canadians’ health through National Pharmacare
A public pharmacare program that provides coverage for all Canadians, regardless of age, occupation, or income, would alleviate financial burdens and allow people to choose jobs based on the work and wages, rather than the cost of the company drug plan.
Questions count when it comes to finding out how Canadians feel about pharmacare
If we want politicians to know what’s important, we need to make sure that they hear answers to questions that get at the heart of the pharmacare issue.
Government hostility to biopharmaceutical industry reduces access to innovative drugs
Developers bring new drugs to Canada later than in other nations. Some aren’t launched here at all. The result is that Canadians who need new drugs either have their access long delayed, or denied.
Multi-payer pharmacare will fail Canadians
Private insurers want Canada to embrace a multi-payer pharmacare system without the tools necessary to protect public interests, promote equity, and ensure value.
